Related Experiment Video
Updated: Jul 5, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Therapeutic Strategies in Children with Epilepsy: A Quality-of-Life-Related Perspective
1Department of Pediatrics, Toho University Medical Center Sakura Hospital, 564-1 Shimoshizu, Sakura 285-8741, Chiba, Japan.
Insights
Seizure severity and EEG abnormalities significantly impact children's quality of life. Early therapeutic management targeting both seizures and interictal epileptiform discharges (IEDs) is crucial for improving outcomes in childhood epilepsy.
Area of Science:
- Pediatric Neurology
- Epileptology
- Neuroscience
Background:
- Childhood epilepsy affects quality of life (QOL) through clinical and social factors.
- Seizure severity, frequent seizures, and status epilepticus (SE) are key QOL predictors.
- Interictal epileptiform discharges (IEDs) on EEG may also predict QOL by causing cognitive and behavioral issues.
Purpose of the Study:
- To investigate the relationship between seizure severity, EEG abnormalities, and QOL in children with epilepsy.
- To explore the role of IEDs, particularly frontal IEDs and secondary bilateral synchrony (SBS), in neuropsychological impairments.
- To identify therapeutic strategies for improving QOL by managing seizures and EEG abnormalities.
Main Methods:
- Analysis of clinical data including seizure severity and frequency.
- Electroencephalogram (EEG) evaluation for interictal epileptiform discharges (IEDs) and secondary bilateral synchrony (SBS).
- Assessment of cognitive and behavioral disturbances as indicators of neuropsychological impairment.
Main Results:
- Seizure severity and IEDs are linked to neuropsychological impairments and reduced QOL.
- Frontal IEDs and SBS are associated with cognitive decline and behavioral disturbances.
- Novel antiseizure medications (ASMs) like levetiracetam and perampanel show potential in suppressing both seizures and IEDs.
Conclusions:
- Reducing seizure severity and EEG abnormalities (frontal IEDs, SBS) is essential for enhancing QOL in pediatric epilepsy.
- Strategic ASM selection, including novel agents, can effectively manage both clinical seizures and EEG abnormalities.
- Early and comprehensive therapeutic interventions are vital for improving long-term outcomes in children with epilepsy.
Abstract:
Back ground: Children with epilepsy are affected by several factors, including clinical and social variables. Among these variables, cognitive decline and behavioral disturbances, perceptions of stigma, and fatigue can lead to reductions in quality of life (QOL). Epileptic activities, including seizure severity, frequent seizures, and status epilepticus (SE), have been identified as important predictors of QOL. In addition, the frequency of interictal epileptiform discharges (IEDs) on electroencephalogram (EEG) may also be an important predictor of QOL, because IEDs can lead to cognitive decline and behavioral disturbances. Moreover, frequent seizures and/or IEDs may play a role in emotional mediators, such as stigma and fatigue, in childhood epilepsy. Seizure severity and/or IEDs are, therefore, important QOL-related factors in childhood epilepsy. Seizure severity as a QOL-related factor: Frontal lobe dysfunctions, such as cognitive decline and behavioral disturbances, can result in reduced QOL for both the child and their family. Frontal and prefrontal lobe growth disturbances can be present during active-phase epilepsy in some children with neuropsychological impairments. Recovery from prefrontal lobe growth disturbances may depend on the active seizure period. Children with a shorter active seizure period can recover from disturbances in prefrontal lobe growth more rapidly. In contrast, recovery may be delayed in children with a longer active seizure period. Moreover, frequent seizures can lead to seizure-associated headaches, perceptions of self-stigma and parental stigma, and fatigue. Accordingly, severe seizures can lead to neuropsychological impairments in association with prefrontal lobe growth disturbances in children with epilepsy. EEG abnormalities as QOL-related factors: IEDs on EEG, representing persistent pathological neuronal discharges, may be associated with several pathological aspects. Frontal IEDs can be a risk factor for recurrent seizures, cognitive decline, and behavioral disturbances, and they may also play a role as emotional mediators similar to stigma. In addition, behavioral disturbances may result in the presence of secondary bilateral synchrony (SBS) on EEG. Behavioral disturbances can be improved in association with a reduction in IEDs in children with frontal IEDs and SBS. Therefore, EEG abnormalities, such as frontal IEDs and SBS, can also lead to neuropsychological impairments in children with epilepsy. Therapeutic strategies in children with epilepsy: Seizure severity and IEDs on EEG may be associated with neuropsychological impairments, leading to QOL reduction. Therapeutic management may be desirable to reduce seizures and EEG abnormalities, such as frontal IEDs and SBS, as early as possible to improve QOL in children with epilepsy. During antiseizure medication (ASM) selection and adjustment, physicians should strategize the therapeutic approach to controlling seizures and suppressing EEG abnormalities in children with epilepsy. Among various ASMs, novel ASMs, such as levetiracetam and perampanel, may suppress both clinical seizures and IEDs on EEG; thus, these novel ASMs may represent an important addition to the treatments available for epileptic children presenting with frontal IEDs and SBS.
Related Concept Videos
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Electroconvulsive Therapy
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

